ESEun-Ju Sohn

Eun-Ju Sohn

*This is an algorithmically generated author record based on publicly available information.

Eun-Ju Sohn has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Dong-Jun An

    Virus Disease Division, Animal and Plant Quarantine Agency, Gimcheon, 39660, Gyeongbuk, Korea

    2 shared publications
  • Inhwan Hwang

    Department of Life Sciences Pohang University of Science and Technology Pohang South Korea

    2 shared publications
  • Jong Kook Kim

    BioApplications Inc., Pohang Techno Park Complex, 394 Jigok-ro Nam-gu, Pohang, Korea

    2 shared publications
  • Kyungmin Min

    BioApplications Inc., Pohang Techno Park Complex, 394 Jigok-ro Nam-gu, Pohang, Korea

    2 shared publications
  • Minhee Park

    BioApplications Inc., Pohang Techno Park Complex, 394 Jigok-ro Nam-gu, Pohang, Korea

    2 shared publications
  • Nam Hyung Kim

    BioApplications Inc., Pohang Techno Park Complex, 394 Jigok-ro Nam-gu, Pohang, Korea

    2 shared publications

Latest Publications

  • Open Access

    A classical swine fever virus E2 fusion protein produced in plants elicits a neutralizing humoral immune response in mice and pigs

    by Youngmin Park, Sangmin Lee, Hyangju Kang, Minhee Park, Kyungmin Min, Nam Hyung Kim, Sungmin Gu, Jong Kook Kim, Dong-Jun An, SeEun Choe, et al.

    Classical swine fever (CSF) is one of the most important viral diseases of swine worldwide. Although live or attenuated virus vaccines have been used to control CSFV, it is difficult to distinguish vaccinated pigs from infected pigs; this leads to restrictions on import and export. Subunit vaccines based on the CSFV E2 glycoprotein have been developed using baculovirus or insect cell systems, but some weaknesses remain. Here, we describe production of an E2 recombinant protein using a Nicotiana benthamiana plant expression system. To do this, we took advantage of the ability of the swine Fc domain to increase solubility and stability of the fusion protein and to strengthen immune responses in target animals. N. benthamiana expressed high amounts of pFc2-fused E2 proteins, which were isolated and purified by affinity chromatography to yield a high pure recombinant protein in a cost-effective manner. Native-polyacrylamide gel electrophoresis and size exclusion chromatography confirmed that the pmE2:pFc2 fusion exists as a multimer rather than as a dimer. Injection of recombinant pmE2 protein into mice or piglets generated anti-pmE2 antibodies with efficient neutralizing activity against CSFV. These results suggest that a purified recombinant E2 protein produced in N. benthamiana generates high titers of neutralizing antibodies in vivo; as such, the protein could be developed as a subunit vaccine against CSFV.


  • Open Access

    Plant-Produced N-glycosylated Ag85A Exhibits Enhanced Vaccine Efficacy Against Mycobacterium tuberculosis HN878 Through Balanced Multifunctional Th1 T Cell Immunity

    by Hongmin Kim, Kee Woong Kwon, Jaehun Park, Hyangju Kang, Yongjik Lee, Eun-Ju Sohn, Inhwan Hwang, Seok-Yong Eum, Sung Jae Shin

    Tuberculosis (TB) is one of the deadliest infectious diseases worldwide and is caused by Mycobacterium tuberculosis (Mtb). An effective vaccine to prevent TB is considered the most cost-effective measure for controlling this disease. Many different vaccine antigen (Ag) candidates, including well-known and newly identified Ags, have been evaluated in clinical and preclinical studies. In this study, we took advantage of a plant system of protein expression using Nicotiana benthamiana to produce N-glycosylated antigen 85A (G-Ag85A), which is one of the most well-characterized vaccine Ag candidates in the field of TB vaccines, and compared its immunogenicity and vaccine efficacy with those of nonglycosylated Ag85A (NG-Ag85A) produced with an Escherichia coli system. Notably, G-Ag85A induced a more robust IFN-γ response than NG-Ag85A, which indicated that G-Ag85A is well recognized by the host immune system during Mtb infection. We subsequently compared the vaccine potential of G-Ag85A and NG-Ag85A by evaluating their immunological features and substantial protection efficacies. Interestingly, G-Ag85A yielded moderately enhanced long-term protective efficacy, as measured in terms of bacterial burden and lung inflammation. Strikingly, G-Ag85A-immunized mice showed a more balanced proportion of multifunctional Th1-biased immune responses with sustained IFN-γ response than did NG-Ag85A-immunized mice. Collectively, plant-derived G-Ag85A could induce protective and balanced Th1 responses and confer long-term protection against a hypervirulent Mtb Beijing strain infection, which indicated that plant-produced G-Ag85A might provide an excellent example for the production of an Mtb subunit vaccine Ag and could be an effective platform for the development of anti-TB vaccines.


  • Open Access

    Development of Recombinant Protein-Based Vaccine Against Classical Swine Fever Virus in Pigs Using Transgenic Nicotiana benthamiana

    by Youngmin Park, Dong-Jun An, SeEun Choe, Yongjik Lee, Minhee Park, Soohong Park, Sungmin Gu, Kyungmin Min, Nam Hyung Kim, Sangmin Lee, et al.

    Classical swine fever virus (CSFV) is highly contagious, and fatal to infected pigs. Vaccines against CSFV have been developed from attenuated or modified live viruses. These vaccines are effective for immunization of animals, but they are associated with problems such as the accidental spreading of viruses to animals in the field, and with barriers to trade following vaccination. Here, we report the generation of transgenic Nicotiana benthamiana plants for large-scale, cost-effective production of E2 fusion protein for use as a recombinant vaccine against CSFV in pigs. Transgenic N. benthamiana plants harboring an intergenic, single-copy insertion of a chimeric gene encoding E2 fusion protein had high levels of transgene expression. For large-scale production of E2 fusion protein from leaf tissues, we developed a protein-purification protocol consisting of cellulose-binding domain (CBD)–cellulose-based affinity purification and size-exclusion gel-filtration chromatography. E2 fusion proteins showed high immunogenicity in piglets and provided protection against CSFV challenge. The CBD in the E2 fusion protein was also highly immunogenic. These results suggest that plant-produced recombinant E2 fusion proteins can be developed into cost-effective vaccines against CSFV, with the CBD as a marker antigen to differentiate between vaccination and natural infection.